0MFU Stock Overview
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.18 |
| 52 Week High | €2.91 |
| 52 Week Low | €0.99 |
| Beta | 0.63 |
| 1 Month Change | -8.23% |
| 3 Month Change | 1.38% |
| 1 Year Change | -59.50% |
| 3 Year Change | -71.50% |
| 5 Year Change | -69.38% |
| Change since IPO | -84.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0MFU | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -1.8% | 0.4% | -0.9% |
| 1Y | -59.5% | 58.7% | -1.8% |
Return vs Industry: 0MFU underperformed the UK Healthcare Services industry which returned 58.7% over the past year.
Return vs Market: 0MFU underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| 0MFU volatility | |
|---|---|
| 0MFU Average Weekly Movement | 8.7% |
| Healthcare Services Industry Average Movement | 7.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0MFU has not had significant price volatility in the past 3 months.
Volatility Over Time: 0MFU's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1867 | 7,000 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
| 0MFU fundamental statistics | |
|---|---|
| Market cap | €182.69m |
| Earnings (TTM) | -€53.00m |
| Revenue (TTM) | €1.15b |
0.2x
P/S Ratio-3.4x
P/E RatioIs 0MFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0MFU income statement (TTM) | |
|---|---|
| Revenue | €1.15b |
| Cost of Revenue | €792.00m |
| Gross Profit | €358.00m |
| Other Expenses | €411.00m |
| Earnings | -€53.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 31.13% |
| Net Profit Margin | -4.61% |
| Debt/Equity Ratio | 3.5% |
How did 0MFU perform over the long term?
See historical performance and comparison